Within the scope of PM, the increase in context‐dependent YAP/TAZ activation on NF2 loss likely translates to a decreased sensitivity to and enhanced proliferative potential within, a tumour niche, with a concurrently increased capacity for anchorage‐independent growth. The gene discussed is WWTR1; the disease is neoplasm.